Literature DB >> 974147

Active transport of butyrobetaine and carnitine into isolated liver cells.

R Z Christiansen, J Bremer.   

Abstract

1. The liver cells lose the major part of their carnitine during the commonly used isolation procedure by the collagenase-perfusion method. 2. The cells take up carnitine and the carnitine precursor butyrobetaine when these substances are added to the medium. The carnitine content of isolated liver cells can increase to about 15 mM with no apparent harm to the cells. 3. The data indicate the existence of a common carrier in the plasma membrane which mediates the uphill transport of both carnitine and butyrobetaine. The carrier has a high affinity for butyrobetaine (Km=0.5 mM) and a lower one for carnitine (Km=5.6 mM). 4. The intracellular butyrobetaine is hydroxylated to carnitine with a rate of approximately 0.33 mumol-g wet weight-1-h-1 which is sufficient to cover the turn over of carnitine in the whole rat. Carnitine is effectively esterified in the liver cells to acetylcarnitine and long-chain acylcarnitines. 5. Both carnitine and acetylcarnitine are released from the cells. The release of both compounds is probably physiological since it was found that acetylcarnitine constitutes a similar fraction of the total acid soluble carnitine both in the blood and liver of the intact rat.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974147     DOI: 10.1016/0005-2736(76)90110-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.

Authors:  M Bronfman; M N Morales; L Amigo; A Orellana; L Nuñez; L Cárdenas; P C Hidalgo
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

4.  Evidence that the production of acetate in rat hepatocytes is a predominantly cytoplasmic process.

Authors:  B Crabtree; M J Souter; S E Anderson
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

5.  Relationship between acid-soluble carnitine and coenzyme A pools in vivo.

Authors:  E P Brass; C L Hoppel
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

6.  gamma-butyrobetaine in tissues and serum of fed and starved rats determined by an enzymic radioisotopic procedure.

Authors:  H Noël; R Parvin; S V Pande
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

7.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  The control of fatty acid metabolism in liver cells from fed and starved sheep.

Authors:  M A Lomax; I A Donaldson; C I Pogson
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

9.  Metabolic fate of non-esterified fatty acids in isolated hepatocytes from newborn and young pigs. Evidence for a limited capacity for oxidation and increased capacity for esterification.

Authors:  J P Pégorier; P H Duée; J Girard; J Peret
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

10.  Changes in muscle free carnitine and acetylcarnitine with increasing work intensity in the Thoroughbred horse.

Authors:  R C Harris; C V Foster
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.